Sertoli cell tumor, a rare testicular tumor, our experience and review of the literature.
OBJECTIVE
We report two new cases of Sertoli cell testicular tumors, and a Cochrane and Medline search of cases published worldwide.


METHODS
We reviewed our series of testicular tumors, the stromal tumor incidence, clinical presentation, treatment and prognosis, and the experience reflected in the literature.


RESULTS
The prevalence of testicular tumors in our health area is of 0.09%, and 2.3% of them are Sertoli cell neoplasms. This figure is slightly higher than the found in other series in which Sertoli tumors range from 0.4% to 1.5% of testicular malignancies in adults and reach 4% in children.


CONCLUSIONS
Sertoli cell tumor has an incidence not exceeding 4%. The most common symptom is a painless mass; in cases with endocrine manifestation, up to 10% are malignant depending on the age of the patient.
Gómez García
Ignacio
I
Urology Department Hospital Virgen de la Salud, Toledo, Spain. naggoga@yahoo.es <naggoga@yahoo.es>
Romero Molina
Marta
M
López-García Moreno
Antonio
A
Buendía González
Elena
E
Rubio Hidalgo
Emilio
E
Bolufer
Eduardo
E
Sampietro Crespo
Antonio
A
Gómez Rodríguez
Antonio
A
D006801:Humans; D008297:Male; D008875:Middle Aged; D012707:Sertoli Cell Tumor / Q000175:diagnosis / Q000601:surgery; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000601:surgery; D055815:Young Adult